Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 158-162 , November 2006

Influence of intravenous contrast agent on dose calculations of intensity modulated radiation therapy plans for head and neck cancer

  • Youngmin Choi

      Affiliations

    • Department of Radiation Oncology, and
    • Corresponding Author InformationCorresponding author. Youngmin Choi, Department of Radiation Oncology, College of Medicine, Dong-A University Hospital, 3-Ga-1 Dongdaesindong, Sugu, Busan 602-175, South Korea.
    • ,
  • Jeung-Kee Kim

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Hyung-Sik Lee

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Won-Joo Hur

      Affiliations

    • Department of Radiation Oncology, and
    • ,
  • Young-Seoub Hong

      Affiliations

    • Department of Preventive Medicine, College of Medicine, Dong-A University Hospital, Sugu, Busan, South Korea
    • ,
  • Sungkwang Park

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea
    • ,
  • Kijung Ahn

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea
    • ,
  • Heunglae Cho

      Affiliations

    • Department of Radiation Oncology, College of Medicine, Inje University, Busan, South Korea

Received 16 January 2006 ,Revised 19 September 2006 ,Accepted 22 September 2006.

References 

  1. Ariji Y, Ariji E, Araki K, Nakamura S, Kanda S. Studies on the quantitative computed tomography of normal parotid and submandibular salivary glands. Dentomaxillofac Radiol. 1994;23:29–32
  2. Barthez PY, Begon D, Delisle F. Effect of contrast medium dose and image acquisition timing on ureteral opacification in the normal dog as assessed by computed tomography. Vet Radiol Ultrasound. 1998;39:524–527
  3. Chu JC, Ni B, Kriz R, Amod Saxena V. Applications of simulator computed tomography number for photon dose calculations during radiotherapy treatment planning. Radiother Oncol. 2000;55:65–73
  4. Coche EE, Duprez T, Lonneux M. Imaging the lymph nodes: CT, MRI, and PET. In:  Grégoire V,  Scalliet P,  Ang KK editor. Clinical target volume in conformal and intensity modulated radiation therapy. Berlin, Heidelberg, New York: Springer-Verlag; 2004;p. 37–67
  5. du Plessis FC, Willemse CA, Lotter MG, Goedhals L. The indirect use of CT numbers to establish material properties needed for Monte Carlo calculation of dose distributions in patients. Med Phys. 1998;25(7 Pt. 1):1195–1201
  6. Eisbruch A. Head and neck cancer: overview. In:  Mundt AJ,  Roeske JC editor. Intensity modulated radiation therapy: a clinical perspective. Ontario: BC Decker Inc.; 2005;p. 264–275
  7. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69:227–236
  8. Han JK, Choi BI, Kim AY, Kim SJ. Contrast media in abdominal computed tomography: optimization of delivery methods. Korean J Radiol. 2001;2:28–36
  9. Heo MS, Lee SC, Lee SS, Choi HM, Choi SC, Park TW. Quantitative analysis of normal major salivary glands using computed tomography. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:240–244
  10. Ida M, Honda E. Age-dependent decrease in the computed tomographic numbers of parotid and submandibular salivary glands. Dentomaxillofac Radiol. 1989;18:31–35
  11. Kassas B, Mourtada F, Horton JL, Lang RG. Contrast effects on dosimetry of a partial breast irradiation system. Med Phys. 2004;31:1976–1979
  12. Kirk MC, Hsi WC, Chu JC, et al. Dose perturbation induced by radiographic contrast inside brachytherapy balloon applicators. Med Phys. 2004;31:1219–1224
  13. Levi C, Gray JE, McCullough EC, Hattery RR. The unreliability of CT numbers as absolute values. AJR Am J Roentgenol. 1982;139:443–447
  14. Liauw SL, Amdur RJ, Mendenhall WM, Palta J, Kim S. The effect of intravenous contrast on intensity-modulated radiation therapy dose calculations for head and neck cancer. Am J Clin Oncol. 2005;28:456–459
  15. Martinez-Madrigal F, Micheau C. Histology of the major salivary glands. Am J Surg Pathol. 1989;13:879–899
  16. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104:1296–1303
  17. Puri DR, Chou W, Lee N. Intensity-modulated radiation therapy in head and neck cancers: dosimetric advantages and update of clinical results. Am J Clin Oncol. 2005;28:415–423
  18. Ramm U, Damrau M, Mose S, Manegold KH, Rahl CG, Bottcher HD. Influence of CT contrast agents on dose calculations in a 3D treatment planning system. Phys Med Biol. 2001;46:2631–2635
  19. Scott J, Flower EA, Burns J. A quantitative study of histological changes in the human parotid gland occurring with adult age. J Oral Pathol. 1987;16:505–510
  20. Wertz H, Jäkel O. Influence of iodine contrast agent on the range of ion beams for radiotherapy. Med Phys. 2004;31:767–773
  21. Wippold FJ. CT and MR imaging of head and neck cancer. In:  Chao KS,  Ozyigit G editor. Intensity modulated radiation therapy for head and neck cancer. Philadelphia: Lippincott Williams & Wilkins; 2003;p. 18–29

PII: S0167-8140(06)00487-7

doi: 10.1016/j.radonc.2006.09.010

Radiotherapy & Oncology
Volume 81, Issue 2 , Pages 158-162 , November 2006

Article Tools

* Image Usage & Resolution